Skip to main content
SpringerLink
Log in

mRNA-based vs viral vector-based COVID-19 vaccines

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. NCT04706156

Reference

  • Klugar M, et al. Side Effects of mRNA-Based and Viral Vector-Based COVID-19 Vaccines among German Healthcare Workers. Biology 10: No. 752, 10 Aug 2021. Available from: URL: http://doi.org/10.3390/biology10080752

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

mRNA-based vs viral vector-based COVID-19 vaccines. Reactions Weekly 1872, 11 (2021). https://doi.org/10.1007/s40278-021-01937-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-01937-y

Search

Navigation